NCT02148328 Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults Status COMPLETED Phase PHASE1
NCT02148211 Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry Status COMPLETED Phase N/A
NCT02141581 Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) Status COMPLETED Phase PHASE4
NCT02134184 The Influence of Chronic CMV Infection on Influenza Vaccine Responses Status COMPLETED Phase PHASE4
NCT02133456 A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older Status COMPLETED Phase N/A
NCT02126761 Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above Status COMPLETED Phase PHASE1
NCT02124096 Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs Status COMPLETED Phase N/A
NCT02121782 A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine) Status COMPLETED Phase PHASE1/PHASE2
NCT02111252 A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT02107807 Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine Status COMPLETED Phase PHASE3
NCT02100436 Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations Status COMPLETED Phase PHASE2
NCT02062281 Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults Status COMPLETED Phase PHASE4
NCT02037282 A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects Status WITHDRAWN Phase PHASE1
NCT02035696 Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old Status COMPLETED Phase PHASE1/PHASE2
NCT02026349 Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316 Status COMPLETED Phase PHASE3